3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione
|
|
|
- CAS-Nr.
- 425637-18-9
- Englisch Name:
- 3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione
- Synonyma:
- CS-1479;Dusquetide;Sotrastaurin;Sotrastaurin (AEB071);Glycerol Impurity 111;AEB071; AEB 071; AEB-071;1H-benzo[d][1,2,3]triazol-5-ol;Sotrastaurin - AEB 071 | NVP-AEB 071;3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione;3-(1H-indol-3-yl)-4-(2-(4-methylpiperazin-1-yl)quinazolin-4-yl)-1H-pyrrole-2,5-dione
- CBNumber:
- CB92510056
- Summenformel:
- C25H22N6O2
- Molgewicht:
- 438.48
- MOL-Datei:
- 425637-18-9.mol
|
3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione Eigenschaften
- Dichte
- 1.406
- storage temp.
- Store at -20°C
- L?slichkeit
- ≥21.9 mg/mL in DMSO; insoluble in H2O; ≥2.55 mg/mL in EtOH with ultrasonic
- Aggregatzustand
- solid
- pka
- 7.39±0.60(Predicted)
- Farbe
- Pink to red
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
| H317 |
Kann allergische Hautreaktionen verursachen. |
Sensibilisierung der Haut |
Kategorie 1A |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P261, P272, P280, P302+P352,P333+P313, P321, P363, P501 |
|
| Sicherheit |
| P280 |
Schutzhandschuhe/Schutzkleidung/Augenschutz tragen. |
|
3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
A potent selective pan-PKC inhibitor and highly inhibits PKCθ with a Ki of 0.22 nM.
Definition
ChEBI: A member of the class of maleimides that is maleimide which is substituted at position 3 by an indol-3-yl group and at position 4 by a quinazolin-4-yl group, which in turn is substituted at position 2 by a 4-methylpiperazin-1-yl group. It is a potent and s
lective inhibitor of protein kinase C and has been investigated as an immunosuppresant in renal transplant patients.
3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 122)Lieferanten
425637-18-9()Verwandte Suche:
- 3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione
- Sotrastaurin
- Sotrastaurin (AEB071)
- 3-(1H-indol-3-yl)-4-(2-(4-methylpiperazin-1-yl)quinazolin-4-yl)-1H-pyrrole-2,5-dione
- Dusquetide
- Sotrastaurin - AEB 071 | NVP-AEB 071
- CS-1479
- AEB071; AEB 071; AEB-071
- 1H-benzo[d][1,2,3]triazol-5-ol
- 1H-Pyrrole-2,5-dione, 3-(1H-indol-3-yl)-4-[2-(4-methyl-1-piperazinyl)-4-quinazolinyl]-
- 3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione USP/EP/BP
- Glycerol Impurity 111
- 425637-18-9
- Smad
- TGF-beta
- Inhibitors
